Teleperformance SE:企業の戦略・SWOT・財務情報

◆英語タイトル:Teleperformance SE - Strategy, SWOT and Corporate Finance Report
◆商品コード:DATA904C0761
◆発行会社(調査会社):MarketLine
◆発行日:2018年7月
◆ページ数:47
◆レポート言語:英語
◆レポート形式:PDF
◆納品方法:Eメール
◆対象地域:フランス
◆産業分野:サービス
◆販売価格オプション(消費税別)
Single User(1名様閲覧用)USD175 ⇒換算¥25,900見積依頼/購入/質問フォーム
Site License(同一事業所内共有可)USD350 ⇒換算¥51,800見積依頼/購入/質問フォーム
Enterprisewide License(複数事業所内共有可)USD525 ⇒換算¥77,700見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日〜2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送しますので、請求書発行日より2ヶ月以内に振込をお願いします。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はMarketLine社の日本における正規販売代理店です。同社発行の企業調査レポートに関するお問い合わせは弊社までお願い致します。
MarketLine社の概要はこちらでご確認いただけます。



【レポートの概要】

Teleperformance SE – Strategy, SWOT and Corporate Finance Report
Summary

Teleperformance SE – Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company’s structure, operation, SWOT analysis, product and service offerings and corporate actions, providing a 360˚ view of the company.

Key Highlights

Teleperformance SE (Teleperformance or “the company”) is a global outsourcing company offering solutions in the fields of customer relations, technical support, customer acquisition, and debt collection. The company offers business transformation solutions including infrastructure and human resources through multi-year contracts and business partnerships. It offers its solutions to companies in financial services, IT, insurance, pharmaceuticals, automotive and transportation, energy and utilities, travel and tourism, media and publishing, manufacturing, Internet service provider (ISP), telecommunications, and public sector and membership services. The company operates across Asia-Pacific, Ibero-LATAM, Continental Europe, Middle East and Africa. Teleperformance is headquartered in Paris, France.

Scope

- Detailed information on Teleperformance SE required for business and competitor intelligence needs
- A study of the major internal and external factors affecting Teleperformance SE in the form of a SWOT analysis
- An in-depth view of the business model of Teleperformance SE including a breakdown and examination of key business segments
- Intelligence on Teleperformance SE’s mergers and acquisitions (MandA), strategic partnerships and alliances, capital raising, private equity transactions, and financial and legal advisors
- News about Teleperformance SE, such as business expansion, restructuring, and contract wins
- Large number of easy-to-grasp charts and graphs that present important data and key trends

Reasons to buy

- Gain understanding of Teleperformance SE and the factors that influence its strategies.
- Track strategic initiatives of the company and latest corporate news and actions.
- Assess Teleperformance SE as a prospective partner, vendor or supplier.
- Support sales activities by understanding your customers’ businesses better.
- Stay up to date on Teleperformance SE’s business structure, strategy and prospects.

【レポートの目次】

Table of Contents
Company Snapshot 2
Table of Contents 5
Teleperformance SE: Company Overview 9
Teleperformance SE: Overview and Key Facts 9
Teleperformance SE: Overview 9
Teleperformance SE: Key Facts 9
Teleperformance SE: Key Employees 10
Teleperformance SE: Key Employee Biographies 11
Teleperformance SE: Major Products and Services 14
Teleperformance SE: Company History 16
Teleperformance SE: Management Statement 20
Teleperformance SE: Locations and Subsidiaries 22
Teleperformance SE: Key Competitors 24
Teleperformance SE: Company Analysis 25
Teleperformance SE: Business Description 25
Teleperformance SE: SWOT Analysis 27
Teleperformance SE: SWOT Overview 27
Teleperformance SE: Strengths 27
Teleperformance SE: Weaknesses 28
Teleperformance SE: Opportunities 28
Teleperformance SE: Threats 29
Teleperformance SE: Corporate Financial Deals Activity 31
Teleperformance SE: Financial Deals Overview 31
Teleperformance SE: Targets and Partners 33
Teleperformance SE: Top Deals 2014 – 2018YTD* 34
Teleperformance SE: Advisors 35
Teleperformance SE: Top Legal Advisors 35
Teleperformance SE: Top Financial Advisors 35
Teleperformance SE: Mergers and Acquisitions 36
Teleperformance SE: Capital Raising 37
Teleperformance SE: Recent Developments 38
Teleperformance SE: News and Events Summary 38
Teleperformance SE: Business Expansion 40
Teleperformance SE: Corporate Governance 42
Teleperformance SE: Financial Performance 42
Teleperformance SE: Red Flags/DistressSignals 43
Teleperformance SE: Regulatory and Legal Events 43
Teleperformance SE: Strategy and Operations 44
Appendix 45
Contact Us 45
Methodology 45
About MarketLine 46

List of Tables
Table 1: Teleperformance SE: Key Facts
Table 2: Teleperformance SE: Key Employees
Table 3: Teleperformance SE: Locations and Subsidiaries
Table 4: Teleperformance SE: Key Competitors
Table 5: Teleperformance SE: Deal Activity by Deal Type - Volume (TTM*)
Table 6: Teleperformance SE: Deal Activity by Deal Type - Volume (2014 - YTD*2018)
Table 7: Teleperformance SE: M&A Average Deal Size - Value (US$m)
Table 8: Teleperformance SE: Targets and Partners
Table 9: Teleperformance SE: Top Deals 2014 - 2018YTD*
Table 10: Teleperformance SE: Legal Advisor Ranking by Value (US$m)
Table 11: Teleperformance SE: Financial Advisor Ranking by Value (US$m)
Table 12: Teleperformance SE: M&A Volume and Value Trend (2014 - YTD*2018)
Table 13: Teleperformance SE: M&A Activity by Geography (2014 - YTD*2018)
Table 14: Teleperformance SE: Capital Raising Volume and Value Trend (2014 - YTD*2018)
Table 15: Teleperformance SE: Capital Raising by Deal Type (2014 - YTD*2018)
Table 16: Teleperformance SE: News and Events Summary
Table 17: Teleperformance SE: Business Expansion
Table 18: Teleperformance SE: Corporate Governance
Table 19: Teleperformance SE: Financial Performance
Table 20: Teleperformance SE: Red Flags/DistressSignals
Table 21: Teleperformance SE: Regulatory and Legal Events
Table 22: Teleperformance SE: Strategy and Operations

List of Figures
Figure 1: Teleperformance SE: Deal Activity by Deal Type - Volume (TTM*)
Figure 2: Teleperformance SE: Deal Activity by Deal Type - Volume (2014 - YTD*2018)
Figure 3: Teleperformance SE: M&A Average Deal Size - Value (US$m)
Figure 4: Teleperformance SE: M&A Volume and Value Trend (2014 - YTD*2018)
Figure 5: Teleperformance SE: M&A Activity by Geography (2014 - YTD*2018)
Figure 6: Teleperformance SE: Capital Raising Volume and Value Trend (2014 - YTD*2018)
Figure 7: Teleperformance SE: Capital Raising by Deal Type (2014 - YTD*2018)

★海外企業調査レポート[Teleperformance SE:企業の戦略・SWOT・財務情報]についてメールでお問い合わせはこちら

■おすすめ企業レポート■
  • Marubeni Corp (8002):石油・ガス:M&Aディール及び事業提携情報
    Summary Marubeni Corp (Marubeni) is an integrated trading and investment business that operates through its domestic and overseas subsidiaries. It provides various products and commodities such as agri and marine products, chemicals, energy, metals and minerals, machinery, textiles, forest products …
  • Empresa Electricidad del Peru SA (ELECPBC1):企業の財務・戦略的SWOT分析
    Empresa Electricidad del Peru SA (ELECPBC1) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key streng …
  • Waste Management Inc (WM):電力:M&Aディール及び事業提携情報
    Summary Waste Management Inc (WM) is a provider of waste management environmental services. The company has presence in the waste management vertical from collection, solid and hazardous waste landfills management, transfer, recycling and resource recovery, to disposal. Through its personal counseli …
  • AU Optronics Corp (2409):電力:M&Aディール及び事業提携情報
    Summary AU Optronics Corp. (AUO) is a provider of optoelectronic solutions. The company designs, develops, manufactures and assembles a wide range of panel display products. Its panels are primarily used in televisions, monitors, mobile PCs, mobile devices and commercial and other applications. It m …
  • SIGA Technologies Inc (SIGA):企業の財務・戦略的SWOT分析
    Summary SIGA Technologies Inc (SIGA) is a health security service provider. The company develops and commercialise solutions for serious unmet medical needs and bio threats. It offers antiviral drug to treat smallpox disease. SIGA offers product such as TPOXX. The company’s Tecovirimat is combined w …
  • BDO International Ltd:企業の戦略的SWOT分析
    BDO International Ltd - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products and …
  • A. Menarini Industrie Farmaceutiche Riunite Srl-製薬・医療分野:企業M&A・提携分析
    Summary A. Menarini Industrie Farmaceutiche Riunite Srl (Menarini), formerly Farmacia Internazionale, is a biopharmaceutical company that undertakes the research, development and manufacture of several pharmaceutical products in various dosage forms. The company’s products portfolio is focused on a …
  • QPS Austria GmbH-製薬・医療分野:企業M&A・提携分析
    Summary QPS Austria GmbH (QPS), a subsidiary of QPS Holdings LLC, is a contract research organization that performs preclinical and clinical research. The company offers in vivo services which involves generating, characterizing and maintaining transgenic disease models and use them for drug testing …
  • GQ Life Sciences Inc-製薬・医療分野:企業M&A・提携分析
    Summary GQ Life Sciences Inc (GQ Life Sciences), formerly GenomeQuest Inc, a subsidiary of Aptean Inc, is a life science information and search company that offers genomic software to search patents for biological sequences. The company provides lifequest, a patent search tool that provides a soluti …
  • Neoleukin Therapeutics Inc (NLTX):企業の財務・戦略的SWOT分析
    Summary Neoleukin Therapeutics Inc (Neoleukin), formely Aquinox Pharmaceuticals Inc is a biopharmaceutical company develops next generation immunotherapies to treat immunological disorders. The company's lead drug candidate NL-201 is a combined IL-2 and IL-15 protein therapeutic used as an agonist i …
  • SandRidge Energy, Inc. (SD):石油・ガス:M&Aディール及び事業提携情報
    Summary SandRidge Energy Inc (SandRidge) is an upstream energy company. It develops, explores for, and produces oil and natural gas in the Mid-Continent and Rockies regions of the US. In Mid-Continent, the company operates assets in Oklahoma and Kansas. In Rockies, SandRidge operates assets within t …
  • Invuity Inc (IVTY):企業の財務・戦略的SWOT分析
    Summary Invuity Inc (Invuity) is a medical technology company that develops and markets advanced surgical devices for the minimally invasive and minimal access procedures. The company offers illuminated surgical retractors, single-use handheld aspiration and universal drop-in intracavity illuminator …
  • Mateon Therapeutics Inc (MATN):企業の財務・戦略的SWOT分析
    Summary Mateon Therapeutics Inc (Mateon), formerly OXiGENE Inc is a biopharmaceutical company developing investigational drugs for the treatment of orphan oncology indications. The company develops therapeutics to treat cancer and eye diseases; and anti-vascular drugs such as vascular disrupting age …
  • Dicerna Pharmaceuticals Inc (DRNA):企業の財務・戦略的SWOT分析
    Summary Dicerna Pharmaceuticals Inc (Dicerna) is a biopharmaceutical company that discovers and develops therapeutics for the treatment of rare inherited diseases and cancers. The company’s lead product DCR-PHXC is used for the treatment of primary hyperoxaluria (PH). It offers RNAi technology platf …
  • InterHealth Nutraceuticals Inc:製薬・医療:M&Aディール及び事業提携情報
    Summary InterHealth Nutraceuticals Inc (InterHealth), a subsidiary of Lonza Group Ltd, is a developer, manufacturer and distributor of nutraceutical ingredients. The company offers nutritional ingredients such as Zychrome, Meratrim, LOWAT, Super CitriMax, ChromeMate, L-OptiZinc, Protykin, ZMA, UC-II …
  • Cochin Shipyard Ltd (COCHINSHIP):企業の財務・戦略的SWOT分析
    Cochin Shipyard Ltd (COCHINSHIP) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and wea …
  • Apotex Inc:企業の戦略的SWOT分析
    Apotex Inc - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products and services. T …
  • Tetra Pak International SA:企業の戦略的SWOT分析
    Tetra Pak International SA - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products …
  • OncoSec Medical Inc (ONCS)-製薬・医療分野:企業M&A・提携分析
    Summary OncoSec Medical Inc (OncoSec) is a biotechnology company that offers services to stimulate body’s immune system and attack cancer. It’s lead candidate, ImmunoPulse IL-12, consists of a plasmid construct encoding the proinflammatory cytokine, IL-12, which is delivered into the tumor through i …
  • GelTech Solutions Inc (GLTC):企業の財務・戦略的SWOT分析
    Summary GelTech Solutions Inc (GelTech Solutions) is a chemical solutions company that manufactures and markets environmentally-friendly chemicals and fire prevention and suppression products. It offers products such as fireice shield and soil2O. Its fireice shield is a fire suppression product that …

◆H&Iグローバルリサーチ株式会社のお客様(例)◆